Ryght
Ryght
Ryght builds AI-driven tools to transform clinical research site selection, feasibility, and trial optimization. Our mission is to shorten study timelines, reduce guesswork, and connect sponsors and CROs with the best research sites worldwide using data-derived digital replicas and predictive analytics.
What we do
Ryght’s core product creates AI Site Twins—dynamic digital replicas of every clinical research site that capture operational characteristics, historical performance, and patient populations. These models power protocol-driven site ranking, feasibility automation, and scenario forecasting to accelerate activation and improve enrollment outcomes.
Who we serve
We serve biopharma sponsors, clinical research organizations (CROs), and research sites. Our platform helps users identify high-potential sites, run AI-powered feasibility questionnaires, and monitor site performance throughout the lifecycle of a trial.
Why it matters
By replacing manual spreadsheets and slow workflows with AI-powered analysis, Ryght reduces timelines and costs while improving trial predictability. The company also provides a free site search engine and is available via major cloud marketplaces to simplify procurement and deployment.
